Quisette P. Janssen

Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment

Stijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker et al. · JAMA Oncology · 2020 · 131 citations · Full text

Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades

Maren H. Harms, Quisette P. Janssen, René Adam et al. · Alimentary Pharmacology & Therapeutics · 2018 · 54 citations · Full text

LBA83 Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial

Bas Groot Koerkamp, Quisette P. Janssen, Jacob L. van Dam et al. · Annals of Oncology · 2023 · 53 citations · Full text

Surgical Oncology, Pancreatic Cancer, Lba83 Neoadjuvant Chemotherapy +10

FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium

Quisette P. Janssen, Jacob L. van Dam, Deesje Doppenberg et al. · JNCI Journal of the National Cancer Institute · 2022 · 45 citations · Full text

Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study

Esther N. Dekker, Jacob L. van Dam, Quisette P. Janssen et al. · Journal of Clinical Oncology · 2024 · 37 citations · Full text